Aug 22 (Reuters) - Telix Pharmaceuticals Ltd (TLX) :
- REAFFIRMS ITS FULL YEAR 2024 REVENUE GUIDANCE OF US$490M TO US$510M
] (([email protected];))
- Forums
- ASX - By Stock
- TLX
- News: TLX Telix Pharmaceuticals Reaffirms Its Full Year 2024 Revenue Guidance
News: TLX Telix Pharmaceuticals Reaffirms Its Full Year 2024 Revenue Guidance
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.73 |
Change
0.290(1.42%) |
Mkt cap ! $6.937B |
Open | High | Low | Value | Volume |
$20.57 | $20.73 | $20.16 | $20.61M | 1.006M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 74 | $20.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.75 | 12799 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 74 | 20.690 |
1 | 600 | 20.680 |
1 | 24991 | 20.540 |
2 | 1056 | 20.530 |
1 | 4676 | 20.520 |
Price($) | Vol. | No. |
---|---|---|
20.750 | 12799 | 5 |
20.760 | 1054 | 2 |
20.780 | 100 | 1 |
20.790 | 10239 | 3 |
20.820 | 24991 | 1 |
Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |